META vs PFE: Which Is the Better Buy?
Side-by-side comparison of Meta Platforms, Inc. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-20.
Meta Platforms, Inc. · Communication Services
$646.01
+43.0% upside to fair value
High Conviction
Grade A
High Quality
VS
Pfizer Inc. · Healthcare
$25.22
+2.8% upside to fair value
Grade B
QuantHub Verdict
META has more upside to fair value
(+43.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
META |
PFE |
| Current Price |
$646.01 |
$25.22 |
| Fair Value Estimate |
$924.09 |
$25.92 |
| Upside to Fair Value |
+43.0%
|
+2.8%
|
| Market Cap |
$1,639.8B |
$143.7B |
| Forward P/E |
—
|
19.2x
|
| EV / EBITDA |
15.0x
|
12.3x
|
| Price / Sales |
7.6x
|
2.3x
|
| Price / FCF |
33.9x
|
15.2x
|
| Revenue Growth YoY |
+33.1%
|
+5.4%
|
| Gross Margin |
81.9%
|
69.3%
|
| Operating Margin |
41.2%
|
23.4%
|
| Return on Equity |
33.2%
|
8.4%
|
| Dividend Yield |
0.33% |
0% |
| FCF Yield |
2.95%
|
6.6%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Meta Platforms operates the Facebook, Instagram, Messenger and WhatsApp ecosystem and monetizes its 3.56 billion Family daily active people primarily through digital advertising. Business quality is high: the core platform combines global network effects, advertiser measurement data, creator supply, cross-app distribution and AI-driven ad ranking, supporting 81.9% gross margin, 41.2% operating ma…
Pfizer Inc. is a leading global biopharmaceutical company with a diversified portfolio dominated by its Biopharma prescription segment, which accounts for over 90% of revenue. The company benefits from a substantial scale, a broad product portfolio including top-selling drugs like Eliquis, Prevnar, and Paxlovid, and a strong manufacturing footprint. However, Pfizer faces challenges from declining…
Accumulation Zones
| Metric |
META |
PFE |
| Zone Low |
$693.07 |
$19.44 |
| Zone High |
$785.48 |
$22.03 |
| In Buy Zone? |
Yes
|
No
|